Most HHT patients have pathogenic variants in one of two known disease-related genes, ENG (endoglin, HHT1) or ACVRL1 (activin A receptor type II-like 1, HHT2), which encode proteins involved in the transforming growth factor ß pathway [2]. Here, ACVRL1 is linked to hereditary hemorrhagic telangiectasia.